Repeated antigen inhalation results in a prolonged airway eosinophilia and airway hyperresponsiveness in primates.
The effects of repeated antigen inhalation on airway cellular composition and airway responsiveness were examined in primates. Airway cellular composition was assessed by bronchoalveolar lavage (BAL), and airway responsiveness was measured as the bronchoconstrictor response to cumulative methacholine dose-response determinations over the course of a 10-wk study. Control animals, exposed to repeated vehicle inhalation challenges, were tested in parallel with the antigen-challenged group. Repeated antigen inhalation resulted in a prolonged inflammatory reaction characterized by a large increase in airway eosinophils (3 +/- 1 to 59 +/- 15%, P less than 0.01). Airway eosinophilia was associated with an increase in airway responsiveness as indicated by a leftward shift in the methacholine dose-response curves, an increase in the slope of the dose-response curves, and a decrease in PC100 values (the dose of methacholine required to cause a 100% increase in lung resistance). The number of BAL eosinophils and the level of eosinophil major basic protein in BAL correlated significantly with methacholine PC100 values (r = 0.61, P less than 0.01 and r = 0.64, P less than 0.01, respectively). Histological examination of lung biopsy samples taken at week 10 of the study demonstrated a striking infiltration of eosinophils in the antigen-challenged animals. These results support earlier observations that demonstrated an association between increases in airway eosinophils and increases in airway responsiveness and suggest that eosinophils are involved in the pathogenesis of hyperresponsive airways.
Gundel
R H
RH
Department of Pharmacology, Boehringer Ingelheim Pharmaceuticals, Ridgefield, Connecticut 06877.
Gerritsen
M E
ME
Gleich
G J
GJ
Wegner
C D
CD
D000280:Administration, Inhalation; D000818:Animals; D000947:Antigens, Helminth / Q000008:administration & dosage / Q000276:immunology*; D001200:Ascaris / Q000276:immunology*; D001980:Bronchi / Q000166:cytology / Q000187:drug effects / Q000276:immunology*; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology*; D004305:Dose-Response Relationship, Drug; D008252:Macaca fascicularis; D008297:Male; D016210:Methacholine Chloride; D008688:Methacholine Compounds / Q000008:administration & dosage / Q000494:pharmacology*; D011657:Pulmonary Eosinophilia / Q000276:immunology*
D000947:Antigens, Helminth; D008688:Methacholine Compounds; D016210:Methacholine Chloride